Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Oncology|September 18, 2004
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growthShuangli Ning, Susanne Fuessel, Matthias Kotzsch, et al.
Scientific Reports|October 25, 2024
Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapyBjoern Thorben Buerk, Cathrin Kusiek, Vayda Schüttke, et al.
International Journal of Molecular Sciences|January 8, 2023
Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell LinesDinah Linke, Lukas Donix, Claudia Peitzsch, et al.
Cancer Letters|February 7, 2006
Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNASusanne Fuessel, Jana Herrmann, Shuangli Ning, et al.
Cancer Letters|June 28, 2005
Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairsSusanne Fuessel, Bernd Weigle, Uta Schmidt, et al.
Frontiers in Oncology|May 14, 2026
PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cellsMax Iltzsche, Nancy Wetterling, Lissy Jilek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosisKaren Bluemke, Udo Bilkenroth, Axel Meye, et al.
Cancers|July 13, 2024
Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active SurveillanceKati Erdmann, Florian Distler, Sebastian Gräfe, et al.
Cancers|September 10, 2021
Increased Sensitivity of Detection of <i>RASSF1A</i> and <i>GSTP1</i> DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCRMarkus Friedemann, Friederike Horn, Katharina Gutewort, et al.
Frontiers in Oncology|February 11, 2020
Linking NRP2 With EMT and Chemoradioresistance in Bladder CancerAlexander Schulz, Ielizaveta Gorodetska, Rayk Behrendt, et al.
Pageof 9